Abstract
In the recent years, a large number of potential biomarkers for Chronic Obstructive Pulmonary Disease (COPD) have been described. One of the important biomarkers is Surfactant Protein D (SPD) since serum SPD levels have been associated with lung function or health status in patients with severe COPD. Several interesting evidences of the protein and gene polymorphisms have been described. The present review highlights the current literature, recent patents and, future prospects of this important collection.
Keywords: Biomarkers, COPD, exacerbations, genetic polymorphism, lung surfactant, SP-D.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Surfactant Protein D in Chronic Obstructive Pulmonary Disease (COPD)
Volume: 8 Issue: 1
Author(s): Dolores Moreno, Alexis Garcia, Diego Lema and Juan B. De Sanctis
Affiliation:
Keywords: Biomarkers, COPD, exacerbations, genetic polymorphism, lung surfactant, SP-D.
Abstract: In the recent years, a large number of potential biomarkers for Chronic Obstructive Pulmonary Disease (COPD) have been described. One of the important biomarkers is Surfactant Protein D (SPD) since serum SPD levels have been associated with lung function or health status in patients with severe COPD. Several interesting evidences of the protein and gene polymorphisms have been described. The present review highlights the current literature, recent patents and, future prospects of this important collection.
Export Options
About this article
Cite this article as:
Moreno Dolores, Garcia Alexis, Lema Diego and De Sanctis B. Juan, Surfactant Protein D in Chronic Obstructive Pulmonary Disease (COPD), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2014; 8 (1) . https://dx.doi.org/10.2174/1872214808666140209142640
DOI https://dx.doi.org/10.2174/1872214808666140209142640 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Revision on Renal Sympathetic Ablation in the Treatment of Resistant Hypertension
Current Hypertension Reviews Development of a Fermentation Process for Utilization of Emblica Officinalis Gaertn (Amla) Candy Waste for Production of Natural Vinegar
Current Nutrition & Food Science Effect of Nitric Oxide Synthase Inhibition on Body Temperature Control During Endotoxemic Shock
Current Enzyme Inhibition Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
Current Pharmaceutical Design The Role of Coronary Collaterals in Chronic Total Occlusions
Current Cardiology Reviews Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases
Current Pharmaceutical Design Engagement of Renin-Angiotensin System in Prostate Cancer
Current Cancer Drug Targets Gene and Stem Cell Therapy in the Treatment of Erectile Dysfunction and Pulmonary Hypertension; Potential Treatments for the Common Problem of Endothelial Dysfunction
Current Gene Therapy Leishmaniasis: Prevention, Parasite Detection and Treatment
Current Medicinal Chemistry A Sweeping Role for MicroRNAs in Neuronal Disease, Vascular Disorders, and as Prognostic Indicators
Current Neurovascular Research Raman Spectroscopy-based Metabonomics of HIV-infected Sera Detects Amino Acid and Glutathione Changes
Current Metabolomics Antithrombotic Treatment in the Prevention of Ischemic Stroke
Current Drug Targets Plant Sterols and Stanols in the Treatment of Dyslipidemia: New Insights into Targets and Mechanisms Related to Cardiovascular Risk
Current Pharmaceutical Design The Impact of Nandrolone Decanoate on the Central Nervous System
Current Neuropharmacology Production of Pancreatic Beta-Cells from Stem Cells
Current Diabetes Reviews Nitric Oxide and the Regulation of Apoptosis in Tumour Cells
Current Pharmaceutical Design Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
Current Neuropharmacology Intelligent Drug Delivery Systems Based on Modified Chitosan Nanoparticles
Letters in Organic Chemistry Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Current Drug Targets The First Line of Defense Against Cardiac Hypertrophy
Current Molecular Medicine